Brief review of Ebola virus disease and the One Health approach (pmc.ncbi.nlm.nih.gov)
0xBASE INTEL BRIEF
- Overview of EVD and One Health approach
- FDA approval of Inmazeb (REGN-EB3) in 2020
- Integration of human, animal, and environmental health
"This article from PMC is a brief review of Ebola virus disease (EVD) and the One Health approach. It notes the FDA approval of Inmazeb (REGN-EB3), a monoclonal antibody for EVD treatment. The review covers transmission, ecology, and integrated disease control strategies linking human, animal, and environmental health."
no comments yet.